Diagnostic use of fluorescence in situ hybridization in expert review in a phase 2 study of trabectedin monotherapy in patients with advanced, translocation-related sarcoma
Crossref DOI link: https://doi.org/10.1186/s13000-016-0486-2
Published Online: 2016-04-12
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sugita, Shintaro
Asanuma, Hiroko
Hasegawa, Tadashi
